AXSM logo

Axsome Therapeutics (AXSM) Company Overview

Profile

Full Name:

Axsome Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 19, 2015

Indexes:

Not included

Description:

Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing new methods of treating diseases of the central nervous system (CNS) for which there are limited treatment options. Founded in 2012, the company is headquartered in New York, USA. The company's portfolio includes 5 drugs that are considered candidate products. They are at different stages of clinical trials: AXS-05 - a drug for reducing depression, also used in smoking cessation. AXS-07 - a drug for treating migraines. AXS-09 - a drug for treating CNS disorders. AXS-12 - a drug for treating narcolepsy. AXS-14 - a drug for treating fibromyalgia. None of the listed drugs have reached the stage of commercial sales.

Key Details

Price

$130.76

Annual Revenue

$385.69 M(+42.53% YoY)

Annual EPS

-$5.99(-13.66% YoY)

Annual ROE

-231.63%

Beta

0.76

Events Calendar

Earnings

Next earnings date:

May 6, 2025

Recent quarterly earnings:

Feb 18, 2025

Recent annual earnings:

Feb 18, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 24, 25 Needham
Buy
Feb 20, 25 HC Wainwright & Co.
Buy
Feb 19, 25 Truist Securities
Buy
Feb 19, 25 RBC Capital
Outperform
Feb 19, 25 Needham
Buy
Feb 19, 25 Cantor Fitzgerald
Overweight
Feb 12, 25 Wells Fargo
Overweight
Feb 11, 25 Mizuho
Outperform
Feb 11, 25 HC Wainwright & Co.
Buy
Feb 11, 25 Deutsche Bank
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Axsome Therapeutics?
  • Does Axsome Therapeutics pay dividends?
  • What sector is Axsome Therapeutics in?
  • What industry is Axsome Therapeutics in?
  • What country is Axsome Therapeutics based in?
  • When did Axsome Therapeutics go public?
  • Is Axsome Therapeutics in the S&P 500?
  • Is Axsome Therapeutics in the NASDAQ 100?
  • Is Axsome Therapeutics in the Dow Jones?
  • When was Axsome Therapeutics's last earnings report?
  • When does Axsome Therapeutics report earnings?
  • Should I buy Axsome Therapeutics stock now?

What is the ticker symbol for Axsome Therapeutics?

The ticker symbol for Axsome Therapeutics is NASDAQ:AXSM

Does Axsome Therapeutics pay dividends?

No, Axsome Therapeutics does not pay dividends

What sector is Axsome Therapeutics in?

Axsome Therapeutics is in the Healthcare sector

What industry is Axsome Therapeutics in?

Axsome Therapeutics is in the Biotechnology industry

What country is Axsome Therapeutics based in?

Axsome Therapeutics is headquartered in United States

When did Axsome Therapeutics go public?

Axsome Therapeutics's initial public offering (IPO) was on November 19, 2015

Is Axsome Therapeutics in the S&P 500?

No, Axsome Therapeutics is not included in the S&P 500 index

Is Axsome Therapeutics in the NASDAQ 100?

No, Axsome Therapeutics is not included in the NASDAQ 100 index

Is Axsome Therapeutics in the Dow Jones?

No, Axsome Therapeutics is not included in the Dow Jones index

When was Axsome Therapeutics's last earnings report?

Axsome Therapeutics's most recent earnings report was on Feb 18, 2025

When does Axsome Therapeutics report earnings?

The next expected earnings date for Axsome Therapeutics is May 6, 2025

Should I buy Axsome Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions